<DOC>
	<DOC>NCT00669474</DOC>
	<brief_summary>Part 1: patients with essential hyperhidrosis are treated one time with suction curettage in both axillae. Part 2: patients with axillary hyperhidrosis receive one treatment with suction curettage in one axilla, and at the same time one treatment with BOTOX injections in the other axilla.</brief_summary>
	<brief_title>Unicentric Comparing Study of Suction Curettage With Standard BOTOX Injection in the Treatment of Patients With Essential Axillar Hyperhidrosis: Comparing of Efficacy, Duration of Effectiveness, and Adverse Events.</brief_title>
	<detailed_description />
	<mesh_term>Hyperhidrosis</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>18 to 75 years Persistent bilateral primary axillary hyperhidrosis Hidrosis interferes with daily activities of patient Gravimetrically minimal 50 mg spontaneous sweat production in each axilla, measured during 5 minutes in room temperature in calm condition signed informed consent patient can and shall continue the trial until the end, and will follow the instructions correcly women in reproductive period had a pregnancy test Medical condition that can be dangerous by treatment with BOTOX, including myastenia gravis, LambertEaton syndrome, ALS, and each other disease that can interfere with the neuromuscular function Secundary hyperhidrosis (for example secundary on hyperthyroid problems, lymfoma, malaria) Known allergy against study medication, his components, local anesthesia or iodium Use of aminoglycosids, curarelike products, or other products which can interfere with the neuromuscular function during the study Use of therapy for hyperhidrosis with Aluminium chlorid during the study Infection or skin disease in the area to treat Participation in an other therapeutic study on the same time Botuline toxine treatment in the last 4 months Women who can or who want to become pregnant Women in reproductive period who don't use the appropriate contraception Patients in a situation of which the researchers decide it can be dangerous, or can interfere with the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>